Factor XIII B Subunit polymorphisms and the risk of coronary artery disease

International Journal of Molecular Sciences

Volumn 16, Issue 1, 2015, Pages 1143-1159

  Mezei, Zoltán A ^a   Bereczky, Zsuzsanna ^a   Katona, Éva ^a   Gindele, Réka ^a   Balogh, Emília ^a   Fiatal, Szilvia ^a   Balogh, László ^a   Czuriga, István ^a   Ádány, Róza ^a   Édes, István ^a   Muszbek, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Coronary artery disease; Factor XIII (FXIII); Factor XIII B subunit (FXIII B); Fibrinogen; Myocardial infarction; Polymorphism; Risk assessment

Indexed keywords

ANTIGEN; APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; BLOOD CLOTTING FACTOR 13; FIBRINOGEN;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COAGULATION FACTOR 13B GENE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; FIBRINOGEN BLOOD LEVEL; GENDER; GENE; GENE FREQUENCY; GENOTYPE; HEART INFARCTION; HOMOZYGOSITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; COMPLICATION; GENETICS; HETEROZYGOTE; INTRON; ODDS RATIO; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FACTOR XIII; FACTOR XIIIA; FEMALE; FIBRINOGEN; GENOTYPE; HETEROZYGOTE; HUMANS; INTRONS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84920546310     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16011143     Document Type: Article

References (45)

1. Komaromi, I.; Bagoly, Z.; Muszbek, L. Factor XIII: Novel structural and functional aspects. J. Thromb. Haemost. 2011, 9, 9-20.
2. Muszbek, L.; Bereczky, Z.; Bagoly, Z.; Komaromi, I.; Katona, E. Factor XIII: A coagulation factor with multiple plasmatic and cellular functions. Physiol. Rev. 2011, 91, 931-972.
3. Schroeder, V.; Kohler, H.P. New developments in the area of factor XIII. J. Thromb. Haemost. 2013, 11, 234-244.
4. Muszbek, L.; Bereczky, Z.; Bagoly, Z.; Shemirani, A.H.; Katona, E. Factor XIII and atherothrombotic diseases. Semin. Thromb. Hemost. 2010, 36, 18-33.
5. Bereczky, Z.; Balogh, E.; Katona, E.; Czuriga, I.; Edes, I.; Muszbek, L. Elevated factor XIII level and the risk of myocardial infarction in women. Haematologica 2007, 92, 287-288.
6. Shemirani, A.H.; Szomjak, E.; Csiki, Z.; Katona, E.; Bereczky, Z.; Muszbek, L. Elevated factor XIII level and the risk of peripheral artery disease. Haematologica 2008, 93, 1430-1432.
7. Ariens, R.A.; Philippou, H.; Nagaswami, C.; Weisel, J.W.; Lane, D.A.; Grant, P.J. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000, 96, 988-995.
8. Balogh, I.; Szoke, G.; Karpati, L.; Wartiovaara, U.; Katona, E.; Komaromi, I.; Haramura, G.; Pfliegler, G.; Mikkola, H.; Muszbek, L. Val34leu polymorphism of plasma factor XIII: Biochemistry and epidemiology in familial thrombophilia. Blood 2000, 96, 2479-2486.
9. Wartiovaara, U.; Mikkola, H.; Szoke, G.; Haramura, G.; Karpati, L.; Balogh, I.; Lassila, R.; Muszbek, L.; Palotie, A. Effect of val34leu polymorphism on the activation of the coagulation factor XIII-A. Thromb. Haemost. 2000, 84, 595-600.
10. Lim, B.C.; Ariens, R.A.; Carter, A.M.; Weisel, J.W.; Grant, P.J. Genetic regulation of fibrin structure and function: Complex gene-environment interactions may modulate vascular risk. Lancet 2003, 361, 1424-1431.
11. Kohler, H.P.; Stickland, M.H.; Ossei-Gerning, N.; Carter, A.; Mikkola, H.; Grant, P.J. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb. Haemost. 1998, 79, 8-13.
12. Bereczky, Z.; Balogh, E.; Katona, E.; Pocsai, Z.; Czuriga, I.; Szeles, G.; Karpati, L.; Adany, R.; Edes, I.; Muszbek, L. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk hungarian population. Thromb. Res. 2007, 120, 567-573.
13. Voko, Z.; Bereczky, Z.; Katona, E.; Adany, R.; Muszbek, L. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis. Thromb. Haemost. 2007, 97, 458-463.
14. Wells, P.S.; Anderson, J.L.; Scarvelis, D.K.; Doucette, S.P.; Gagnon, F. Factor XIII Val34Leu variant is protective against venous thromboembolism: A huge review and meta-analysis. Am. J. Epidemiol. 2006, 164, 101-109.
15. Board, P.G. Genetic polymorphism of the B subunit of human coagulation factor XIII. Am. J. Hum. Genet. 1980, 32, 348-353.
16. Leifheit, H.J.; Cleve, H. Analysis of the genetic polymorphism of coagulation factor XIIIB (FXIIIB) by isoelectric focusing. Electrophoresis 1988, 9, 426-429.
17. Komanasin, N.; Catto, A.J.; Futers, T.S.; van Hylckama Vlieg, A.; Rosendaal, F.R.; Ariens, R.A. A novel polymorphism in the factor XIII B-subunit (His95Arg): Relationship to subunit dissociation and venous thrombosis. J. Thromb. Haemost. 2005, 3, 2487-2496.
18. International Hapmap Project. Available online: http://hapmap.ncbi.nlm.nih.gov?(accessed on 15 October 2014).
19. Pruissen, D.M.; Rosendaal, F.R.; Frijns, C.J.; Kappelle, L.J.; Vos, H.L.; Algra, A. Prothrombotic gene variants and mortality after cerebral ischemia of arterial origin. Neuroepidemiology 2011, 37, 109-113.
20. Reiner, A.P.; Heckbert, S.R.; Vos, H.L.; Ariens, R.A.; Lemaitre, R.N.; Smith, N.L.; Lumley, T.; Rea, T.D.; Hindorff, L.A.; Schellenbaum, G.D., et al. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Blood 2003, 102, 25-30.
21. Iwata, H.; Kitano, T.; Umetsu, K.; Yuasa, I.; Yamazaki, K.; Kemkes-Matthes, B.; Ichinose, A. Distinct C-terminus of the B subunit of factor XIII in a population-associated major phenotype: The first case of complete allele-specific alternative splicing products in the coagulation and fibrinolytic systems. J. Thromb. Haemost. 2009, 7, 1084-1091.
22. Ryan, A.W.; Hughes, D.A.; Tang, K.; Kelleher, D.P.; Ryan, T.; McManus, R.; Stoneking, M. Natural selection and the molecular basis of electrophoretic variation at the coagulation F13B locus. Eur. J. Hum. Genet. 2009, 17, 219-227.
23. Thygesen, K.; Alpert, J.S.; Jaffe, A.S.; Simoons, M.L.; Chaitman, B.R.; White, H.D.; Katus, H.A.; Apple, F.S.; Lindahl, B.; Morrow, D.A., et al. Third universal definition of myocardial infarction. J. Am. Coll. Cardiol. 2012, 60, 1581-1598.
24. Katona, E.; Penzes, K.; Csapo, A.; Fazakas, F.; Udvardy, M.L.; Bagoly, Z.; Orosz, Z.Z.; Muszbek, L. Interaction of factor XIII subunits. Blood 2014, 123, 1757-1763.
25. Girolami, A.; Burul, A.; Fabris, F.; Cappellato, G.; Betterle, C. Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups. Folia Haematol. 1978, 105, 131-141.
26. Capellato, M.G.; Lazzaro, A.R.; Marafioti, F.; Polato, G.; Girolami, A. A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiency. Haematologia 1987, 20, 179-187.
27. Saito, M.; Asakura, H.; Yoshida, T.; Ito, K.; Okafuji, K.; Yoshida, T.; Matsuda, T. A familial factor XIII subunit B deficiency. Br. J. Haematol. 1990, 74, 290-294.
28. Hashiguchi, T.; Saito, M.; Morishita, E.; Matsuda, T.; Ichinose, A. Two genetic defects in a patient with complete deficiency of the B-subunit for coagulation factor XIII. Blood 1993, 82, 145-150.
29. Rodeghiero, F.; Tosetto, A. Factor XIII subunit B deficiency. Br. J. Haematol. 1990, 76, 317.
30. Rodeghiero, F.; Tosetto, A.; di Bona, E.; Castaman, G. Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiency. Am. J. Hematol. 1991, 36, 30-34.
31. Souri, M.; Koseki-Kuno, S.; Takeda, N.; Degen, J.L.; Ichinose, A. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice. Int. J. Hematol. 2008, 87, 60-68.
32. Polgar, J.; Hidasi, V.; Muszbek, L. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem. J. 1990, 267, 557-560.
33. Souri, M.; Kaetsu, H.; Ichinose, A. Sushi domains in the B subunit of factor XIII responsible for oligomer assembly. Biochemistry 2008, 47, 8656-8664.
34. Tuut, M.; Hense, H.W. Smoking, other risk factors and fibrinogen levels. Evidence of effect modification. Ann. Epidemiol. 2001, 11, 232-238.
35. Lanktree, M.B.; Hegele, R.A. Gene-gene and gene-environment interactions: New insights into the prevention, detection and management of coronary artery disease. Genome Med. 2009, 1, 28.
36. Bereczky, Z.; Balogh, E.; Katona, E.; Czuriga, I.; Karpati, L.; Shemirani, A.H.; Edes, I.; Muszbek, L. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease. Thromb. Res. 2008, 121, 469-476.
37. Montagnana, M.; Danese, E.; Lippi, G. Genetic risk factors of atherothrombosis. Pol. Arch. Med. Wewn. 2014, 124, 474-482.
38. Kunicki, T.J.; Williams, S.A.; Nugent, D.J. Genetic variants that affect platelet function. Curr. Opin. Hematol. 2012, 19, 371-379.
39. Fedele, F.; Mancone, M.; Chilian, W.M.; Severino, P.; Canali, E.; Logan, S.; de Marchis, M.L.; Volterrani, M.; Palmirotta, R.; Guadagni, F. Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease. Basic Res. Cardiol. 2013, 108, 387.
40. Stephen, B.H.; Steven, R.C.; Warren, S.B.; Deborah, G.G.; Thomas, B.N. Designing Clinical Research, 3rd ed.; Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2007.
41. Széles, G.; Voko, Z.; Jenei, T.; Kardos, L.; Pocsai, Z.; Bajtay, A.; Papp, E.; Pasti, G.; Kosa, Z.; Molnar, I., et al. A preliminary evaluation of a health monitoring programme in Hungary. Eur. J. Public Health 2005, 15, 26-32.
42. Shemirani, A.H.; Muszbek, L. Rapid detection of the factor XIII Val34Leu (163 G→T) polymorphism by real-time pcr using fluorescence resonance energy transfer detection and melting curve analysis. Clin. Chem. Lab. Med. 2004, 42, 877-879.
43. Karpati, L.; Penke, B.; Katona, E.; Balogh, I.; Vamosi, G.; Muszbek, L. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin. Chem. 2000, 46, 1946-1955.
44. Katona, E.; Haramura, G.; Karpati, L.; Fachet, J.; Muszbek, L. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2). Thromb. Haemost. 2000, 83, 268-273.
45. Cortina-Borja, M.; Smith, A.D.; Combarros, O.; Lehmann, D.J. The synergy factor: A statistic to measure interactions in complex diseases. BMC Res. Notes 2009, 2, 105.